- Home
- AVTX vs DAVA Comparison
AVTX vs DAVA Comparison
Compare AVTX & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | DAVA |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.9M | 365.7M |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AVTX | DAVA |
|---|---|---|
| Price | $17.10 | $5.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $32.57 | $14.57 |
| AVG Volume (30 Days) | ★ 510.9K | 469.8K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.66 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.80 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $3.39 | $4.38 |
| 52 Week High | $20.72 | $22.94 |
Technical Indicators
Market Signals| Indicator | AVTX | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | 44.49 |
| Support Level | $15.36 | $4.85 |
| Resistance Level | $19.26 | $7.04 |
| Average True Range (ATR) | 1.36 | 0.31 |
| MACD | 0.07 | 0.10 |
| Stochastic Oscillator | 65.50 | 57.78 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.